Affordable Access

Publisher Website

Potential role of mesenchymal stromal cells in pancreatic islet transplantation

Authors
Journal
Transplantation Reviews
0955-470X
Publisher
Elsevier
Volume
27
Issue
1
Identifiers
DOI: 10.1016/j.trre.2012.11.003
Disciplines
  • Biology
  • Ecology
  • Geography
  • Medicine

Abstract

Abstract Pancreatic islet transplantation is an attractive option for treatment of type 1 diabetes mellitus but maintaining long term islet function remains challenging. Mesenchymal stromal cells (MSCs), derived from bone marrow or other sources, are being extensively investigated in the clinical setting for their immunomodulatory and tissue regenerative properties. Indeed, MSCs have been already tested in some feasibility studies in the context of islet transplantation. MSCs could be utilized to improve engraftment of pancreatic islets by suppressing inflammatory damage and immune mediated rejection. In addition to their immunomodulatory effects, MSCs are known to provide a supportive microenvironmental niche by secreting paracrine factors and depositing extracellular matrix. These properties could be used for in vivo co-transplantation to improve islet engraftment, or for in vitro co-culture to prime freshly isolated islets prior to implantation. Further, tissue specific pancreatic islet derived MSCs may open new opportunities for its use in islet transplantation as those cells might be more physiological to pancreatic islets.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

[The role of mesenchymal stromal cells in solid or...

on Revue médicale suisse Aug 27, 2014

Role of mesenchymal stromal cells in solid organ t...

on Transplantation Reviews Jan 01, 2008

Mesenchymal stem cells help pancreatic islet trans...

on World journal of stem cells Apr 26, 2014

Rationale for the potential use of mesenchymal str...

on World Journal of Gastroenterol... Nov 28, 2014
More articles like this..